China SXT Pharmaceuticals, Inc.
SXTC · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,304 | -$3,099 | -$5,935 | -$5,736 |
| Dep. & Amort. | $82 | $203 | $250 | $320 |
| Deferred Tax | $0 | $0 | $3,225 | $328 |
| Stock-Based Comp. | $0 | $352 | $555 | $2,334 |
| Change in WC | -$972 | -$382 | $1,416 | $1,903 |
| Other Non-Cash | $1,848 | $997 | $409 | $1,119 |
| Operating Cash Flow | -$2,345 | -$1,928 | -$81 | $268 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$7 | -$71 | -$62 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $66 | $33 | $58 | $16 |
| Investing Cash Flow | $64 | $26 | -$12 | -$47 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$65 | $1,308 | $4,005 | $2,772 |
| Stock Issued | $2,760 | $0 | $2,195 | $3,115 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,704 | -$3,933 | -$3,258 | -$4,292 |
| Financing Cash Flow | $8,399 | -$2,624 | $2,942 | $1,595 |
| Forex Effect | -$65 | -$765 | -$1,050 | $394 |
| Net Chg. in Cash | $6,052 | -$5,291 | $1,799 | $2,211 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,077 | $17,368 | $15,570 | $13,359 |
| End Cash | $18,129 | $12,077 | $17,368 | $15,570 |
| Free Cash Flow | -$2,347 | -$1,935 | -$151 | $206 |